Wegovy Access Expands to Millions in US on Medicare, Study Finds

  • 📰 BNNBloomberg
  • ⏱ Reading Time:
  • 19 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 11%
  • Publisher: 50%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Medicare’s recent decision to cover Novo Nordisk A/S’s blockbuster obesity shot Wegovy for heart disease will possibly subsidize the drug for some 3.6 million people, according to a new study from Kaiser Family Foundation.

Wegovy Access Expands to Millions in US on Medicare, Study FindsAirlines Must Now Pay Automatic Refunds for Canceled FlightsUBS Chairman Says He’s Seriously Concerned Over Capital ReformsCocoa Price Swings Are the Craziest Since the 1970sFrench Grid Issues Are Causing Power Prices to Soar in EuropeASML CEO Wennink’s Exit Leaves US-China Semiconductor Fight to SuccessorTesla to Accelerate Launch of Cheaper Cars After Sales MissUBS Chairman Says He’s Seriously Concerned Over Capital ReformsFrench...

Corruption ProbeCVC and Puig Debuts Set to Test Strength of Europe’s IPO ReboundIn Jammu, Modi Seeks Approval for Scrapping Kashmir Autonomy: India VotesSome LDP Members Oppose BOJ Rate Hikes Ahead of Political EventsSenate Sends Aid Package With Iran Oil Sanctions to BidenASML CEO Wennink’s Exit Leaves US-China Semiconductor Fight to SuccessorUS Regulator Seeks $5.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 83. in HEALTH

Health Health Latest News, Health Health Headlines